A B S T R A C T We studied the effect of furosemide on pulmonary oxygen exchange, lung liquid, and central hemodynamics in dogs with pulmonary capillary leak induced by intravenous oleic acid (OA). 2 h after OA, triple indicator-dilution lung liquid volume and pulmonary shunt (Qs/Qt) doubled despite normal pulmonary capillary wedge pressure in 16 dogs compared with dogs not given OA in which no variable change during the same time. Six edematous dogs were then treated with furosemide (1 mg/kg), and 2 h later they showed significant reductions in Qs/Qt and lung liquid. In contrast, six other edematous dogs not given furosemide increased Qs/Qt and lung liquid during the same time. The changes in edema after furosemide could not be attributed to altered wedge or colloid osmotic pressures, and similar changes in Qs/Qt and lung liquid with furosemide were observed in four nephrectomized dogs. We conclude that pulmonary vasoactive effects of furosemide account for reduced shunt and edema in canine pulmonary capillary leak. These effects of furosemide differ from those in cardiogenic pulmonary edema, and suggest a different rationale for diuretic therapy in low-pressure pulmonary edema. Analysis of count rates from 5'Cr-labeled erythrocytes and 1251_ labeled albumin in lungs excised from 12 dogs indicated that the composition of excess lung liquid did not change with furosemide, and was 50% plasma, 25% blood, and 25% crystalloid.
INTRODUCTION
Diuretics have long been used to treat pulmonary edema secondary to left heart failure. Their effectiveness is attributable to the reduced filling pressure of the left heart and pulmonary capillaries, which results when central blood volume is reduced by diuresis and by the diuretic enhanced capacitance of the systemic venous bed (1) (2) (3) (4) (5) (6) . Conceivably, such other mechaReceived for publication 11 May 1979 and in revised form 29 June 1979. 1494 nisms as increased plasma oncotic pressure or increased pulmonary lymph flow also reduce the pulmonary edema. Another form of pulmonary edema in which there is no evidence of left heart failure and the pulmonary capillary pressure is normal or low is now frequently recognized (7, 8) . Increased permeability of the pulmonary capillary to plasma constituents has been proposed to explain this disorder, and several animal models have been developed which simulate aspects of it. After the intravenous injection of oleic acid in dogs, hemorrhagic pulmonary edema and severe hypoxemia secondary to true intrapulmonary shunt develop in the absence of elevated pulmonary artery wedge pressure (9) . The histopathologic changes and the hypoxemia seen in this model closely resemble the findings in human subjects dying from posttraumatic pulmonary insufficiency (9) . This study was designed to determine whether furosemide alters the course of low-pressure pulmonary edema by studying the canine oleic acid model, and to determine if this alteration is related to diuresis. 14 and 29 kg were studied. Each was anesthetized with pentobarbital (29 mg/kg), and ventilated with oxygen and halothane (0.5%) with a tidal volume of 20 cm3/kg and a respiratory rate of 15/min. Each animal was heparinized with 200 IU of sodium heparin/kg body wt. Polyethylene catheters were placed in the femoral artery and vein, and a thermal dilution SwanGanz catheter (Edwards Laboratories, Inc., Santa Ana, Calif.) was positioned in the pulmonary artery. A French Foley catheter (No. 14, Edwards Laboratories, Inc.) was inserted in the bladder by cystostomy. All animals had a midline abdominal incision through which both kidneys were mobilized. In a group of four dogs (group OA + NE + F), the renal pedicles were completely ligated causing effective nephrectomy whereas in the others the kidneys were not altered other than the mobilization procedure.
GLOSSARY OF SYMBOLS
After control measurements, OA (0.06 ml/kg) was injected intravenously in three groups of dogs (group OA, group OA + NE + F, and group OA + F). Measurements were made after 2 h, and then furosemide (1 mg/kg) was injected intravenously in group OA + NE + F, group OA + F and group F. Group OA animals received no furosemide. Group OA and group OA + F consisted of six animals each, and the fourth group (group F), which consisted of four animals, received furosemide only. The measurements were repeated at 4 h (i.e., 2 h postfurosemide). This design allowed assessment of the effect of furosemide on OA pulmonary edema by comparing 2-and 4-h measurements in intact dogs (group OA vs. group OA + F) and nephrectomized dogs (group OA vs. group OA + NE + F).
Pulmonary artery (Ppa), pulmonary wedge (Ppv), and systemic blood pressure were measured with Statham vascular pressure transducers (P23 DB and BB, Statham Instruments, Inc., Oxnard, Calif.) coupled to a multichannel Beckman Oscillographic recorder (Beckman Instruments, Inc., Fullerton, Calif.). Cardiac output (Qt) was measured by thermodilution (Columbus Instruments, Columbus, Ohio), and pulmonary vascular resistance (PVR) was calculated: PVR = (Ppa -Ppw)/ Qt. Arterial and mixed venous blood samples were collected in heparinized syringes and analyzed immediately for pH, Pco2, and Po2 on a Corning 165-2 blood gas analyzer (Corning Glass Works, Corning, N. Y.), and for hemoglobin concentration (Hb, grams per 100 milliliters). Mixed expired gases were collected and analyzed for PEO2 and PECO2 using the same electrodes, and these values were used to estimate pulmonary capillary and alveolar 02 tension (PAO2 = PEO2 + PEC02 -PaCO2). Blood gas tensions were corrected to blood temperature, and oxygen saturations were calculated using the nomogram of Rossing and Cain (10) . Oxygen contents in arterial (CaO2), mixed venous (CvO2), and pulmonary capillary (Cc'02) blood were calcuilated as: percent saturation x (Hb, g/100 ml x 1.34) + Po2 x 0.003. These were used to estimate shunt (Qs/Qt). QsIQt = (Cc'02 -CaO2)/(Cc'02 -CvO2). Serum albumin, globulin, and total proteins were also measured in arterial blood by the Biuret and bromo-cresol green techniques.
Estimates of central blood volume (CBV) and pulmonary extravascular lung water (Vw) were made at control, 2, and 4 h in four animals from each group according to indicator-dilution techniques described in detail by Kirk (11) . Briefly, a solution of 5'Cr-labeled erythrocytes (30 mCi), '251-labeled human serum albumin (8 mCi), and tritiated water (HTO) (25 mCi) was injected into the right ventricle and sampled at 1-s intervals from the root of the aorta. 5'Cr-and '251-gamma activities of an ethanol precipitate were determined in a 400-channel analyzer with corrections for background and spillover, and HTO activity was determined in an ethanol extract by a Nuclear-Chicago MKI liquid scintillation counter (NuclearChicago Corp., Des Plaines, Ill). Assuming that erythrocytes do not leave the circulation in a single pass, we calculated blood flow (Q) from the dilution curves for 5'Cr. CBV was calculated by the product of Q and the mean transit time (i) of cells, and represents the volume of blood from the right ventricle to the root of the aorta. Vw was calculated as suggested by Chinard et al. (12) where Vw = (Q t HTO) -CBV fB, and fB is the water content ofblood at the central hematocrit.
The liquid composition of excised lungs was determined (11). 20 min after the final dilution curve in each animal, blood samples were drawn for final blood activity of 5'Cr and 125I. The thorax was opened rapidly through a median sternotomy. Clamps were placed on the lung hilae, and the lungs that contained blood were excised and weighed wet (WW). They were then homogenized in a Waring blender (Waring Products Div., New Hartford, Conn.) with 20 ml of distilled water. The homogenate volume (VH) was measured after overnight settling. Duplicate 2-ml aliquots of lung homogenate and 0.5-ml aliquots of blood were counted for 5'Cr and 125I, expressed as counts per minute per milliliter of each (CB, CH). The volume ofblood (VB) in the excised lungs was then calculated for each isotope. VB = (CH-VH)/CB. We assumed that differences in VB between 5'Cr and 125I represent a different volume of distribution of cells and plasma within the lung, and expressed this difference as lung plasma in excess of lung blood (Vp).
The remaining homogenate was dried to a constant weight in a vacuum oven at 60°C and 400 torr of absolute pressure to obtain dry weight (DW significant reduction in Ppw between 2 and 4 h in group OA (no furosemide) compared with a smaller and insignificant fall in group OA + F. Both groups showed similar mean reduction in Qt, although this trend in group OA was not statistically significant (0.05 < P < 0.1). PVR increased in all groups receiving furosemide, but the mean increase in group OA (no furosemide) was smaller and not statistically significant. Urine output was similar in all nonnephrectomized groups before and after OA, and increased considerably after furosemide (Table II) . Compared with group OA, there was a 300-ml greater urine output in group OA + F during the 2 h after furosemide. This was associated with reduced mean Qs/Qt and increased mean PaO2 without lowering mean Ppw as much as in group OA. Furthermore, even with no urine output after furosemide, the nephrectomized dogs (group OA + NE + F) did not increase their shunt or decrease their PaO2 as did the dogs in group OA. Table III summarizes the results of serum albumin and globulin measurements and analysis. There were no differences among groups at time 0 (control), and both proteins tended to decrease slightly by 2 and 4 h. These trends were not significant in any group, and there were no differences among groups after OA or after furosemide.
WW and DW from the four dogs not given OA (group F) did not vary much (Table IV) . All of these values are within the normal range, and the mean wet:dry weight ratio (W/D) was 3.85. As calculated from the 51Cr-labeled erythrocyte activity in the excised lung homogenate, about one-third (3.2 ml/kg) of the WW (9.4 g/kg) was blood (VB). The lung blood was also calculated from '251-labeled albumin in the lung homogenate. These values are expressed in Table IV (Vp, ml/kg) as the lung blood calculated from 1251 less the [51Cr]VB. The small difference between these two estimates of lung blood volume in each normal dog averaged zero, which indicates that lung blood and plasma were in the same proportion as in the vascular space. Blood-free extravascular lung water averaged 6.2 ml/kg body wt (Table IV , H20 ml/kg). In these four dogs the hematocrit at the end ofthe experiment ranged from 46 to 60%, and gave blood W/D values from 3.9 to 2.9, and the blood-free lung W/D values ranged from 3.5 to 4.5 (mean 4.07). The excised lungs of 12 dogs given OA had doubled WW and a small increase in DW (Table IV) compared with group F. The W/D were larger in all dogs receiving furosemide after OA (group OA + F) than in all dogs receiving only OA. In the nine OA treated dogs in which estimates of lung blood were obtained with both 5'Cr-labeled erythrocytes and '251-labeled albumin, the mean WW was 20.9+±2.7 (Table IV 29±10  33±15  177±68  201+48  F  29±+10  43+21  128+62  155±21 * Hourly collections at times after OA injection. 4 Mean±SD. between this mean and the corresponding mean WW in group F indicates that OA caused -11.5 ml/kg of excess lung liquid. Blood accounted for 6.2±2.4 ml/kg of the WW in those nine OA-treated dogs, which indicates an average increase in lung blood after OA of 3.0 ml/kg compared with group F. This blood may be interstitial or intravascular and accounted for about one-quarter of the excess of lung liquid. There was no obvious difference in the amount of excess blood among OA, OA + NE + F, and OA + F.
In each of these dogs, the lung blood calculated from 125I exceeded that calculated from 5'Cr (Table IV) . We assumed that this indicated greater plasma than blood leak, and we tabulated the difference between these values as the plasma leak in excess of blood leak (Vp). This averaged 5.3 ml/kg after OA and 0 ml/kg in group F, which indicates that OA caused a leak of cell-free plasma accounting for about one-half of the excess lung liquid. Again, there was no obvious difference in plasma leak among the other groups. The remaining 28% of the To assess the accuracy of in vivo estimates of extravascular lung water by indicator dilution in this study, we plotted Vw against actuial extravascular water content (Vwa) of the excised lungs (Fig. 3) . Vwa was calculated by subtracting the blood volume of lung from the W/D differeince. This underestimates Vwa by the water content of extravascular lung blood. Group F values cluster about the identity line, and the average Vw/Vwa value was 0.95. In contrast, Vwa was underestimated by indicator dilution in all dogs treated with OA. There was Ino obvious difference in the amount of underestimiiation in the dogs given furosemide after OA (mean±SD, Vw/Vwa = 0.59±0.08, n = 6) from the group OA dogs (mean±SD, Vw/Vwa = 0.61±0.14, n = 4 Table IV and Fig. 2 . One surprising finding in this study was that the improvement in gas exchange was not obviously associated with reduced pulmonary edema. In fact, the W/D of the excised lungs suggest that edema may be worse in the furosemide-treated group OA + F than in group OA. However, confident assessment of the relative amount of excess lung liquid from our data was more difficult than we anticipated. In the following discussion, we consider several interpretations of the results of excess lung liquid and its composition derived from our in vivo indicator-dilution techniques and our excised lung measurements. We also attempt to relate these considerations to our measurements of factors governing lung liquid in OA pulmonary edema. Finally, we attempt to use the possible conclusions concerning lung liquid balance and central hemodynamic effects of furosemide to explain how furosemide decreased pulmonary shunt. Amount and composition of excess lung liquid. Of several methods to determine the amount of extravascular lung water, the most direct is to subtract DW and lung blood volume (VB) from the WW of excised lungs (14) . This approach was partially confounded in our study because about one-fourth of the excess lung liquid was blood, which could be intravascular or extravascular. Based on the gross appearance of the excised lung, on the reported histology of canine OA pulmonary edema demonstrating interstitial and alveolar erythrocytes (9) , and on the similarity of our CBV estimates in all groups in this study, we think that most of the excess blood is extravascular. Nevertheless, the amount of lung liquid was not obviously different among groups OA + NE + F and OA + F (furosemide) and group OA (no furosemide) when it was estimated (Table IV) as either WW-DW (viz., no intravascular blood) or WW-DW-VB (viz., all the blood is intravascular). All three OA groups had more than twice the lung liquid content of group F. Accordingly, OA caused hemorrhagic pulmonary edema, and it seems unlikely that there was less lung liquid in excised lungs of the furosemide-treated groups.
An alternative index quantitating pulmonary edema is the W/D. W/D has the potential advantage of normalizing lung liquid volume to an index of lung mass (DW). This was also partially confounded in our study because the total excess extravascular lung liquid contained substantial nonevaporable substance in the form of25% blood (mean W/D -3.5) and a further 50% excess plasma (mean W/D -16.0). In the nine OA-treated excised lungs in which blood and plasma content were determined, there were no obvious differences in amount of excess blood or plasma between furosemidetreated groups and group OA (Table IV) . Furthermore, furosemide did not influence CBV estimates (Fig. 2) . These arguments suggest that the strong trend toward higher W/D in group OA + F than in group OA is not a result of artifacts introduced by variable W/D of edema liquid between the groups, but, rather, indicates that the furosemide groups had more pulmonary edema.
Regardless of whether group OA + F dogs had similar or greater edema than group OA, the in vivo indicator estimates of Vw suggest that furosemide reduced edema accumulation after OA. Our values of Vw were not aecurate in OA edema because the 4-h measurements averaged =60% of the actual water content of excised lungs (Fig. 3) . Assuming the same relationship (Vw/Vcwa x 0.6) at 2 h, mean Vwa would be less in group OA (9.0 ml/kg) than group OA + F (11.5 ml/kg) or group OA + NE + F (11.3 ml/kg). Although the scatter is wide among these 12 dogs, these data suggest the possibility that group OA + F animals received, by chance, a larger OA lesion and developed greater pulmonary edema by 2 h than did group OA animals. Furthermiiore, during the next 2 h, three of four group OA animals increased Vwa, and the mean value increased to 11.5 ml/kg. In contrast, furosemide treatment was associated with reduced Vwa between 2 and 4 h in five of eight animals in groups OA + NE + F and OA + F, and mean Vwa at 4 h tended to decrease after fuirosemide. We wondered whether these results might be a result of greater underestimation of VwNa by indicator dilution after furosemide, but the results in Fig. 3 do not support an obviously different Vw/Vw"a among the OA groups. Accordingly, our data do not exclude the possibility that furosemide treatmiient decreased lung water even though the actual water content and W/D of excised lungs wvas as large or larger in group OA + F than in group OA.
We conclude that our indicator-dilution and excisedlung studies did not clearly demonstrate an effect of furosemide on canine OA pulmonary edema. This shortfall was in part because of the complex composition of OA pulmonary edema, which this study quantitated for the first time. The excess lung liquid measured 4 h after 0.06 ml/kg OA was administered intravenously consisted of -50% cell-free plasma,-25% whole blood, and -25% crystalloid. These findings are consistent with the notion that intravenous OA causes a range of lesions increasing pulmonary vascular permeability to water, plasma proteins, and erythrocytes. One consequence ofthe observed vascular permeability to plasma proteins is a marked reduction in potential therapeutic effectiveness of raising vascular colloid oncotic pressuire in low-pressure pulmonary edema (15) .
Effect offurosemide on factors governing lung liquid balance. The major factors governing the net flow of lung liquid (QE) from pulmonary microvessels (mv) to lung interstitium (is) may be expressed in the e(quation: QE = Kf[(Pmv -Pis) -(7rmv -ris)of] -Q lymph, where P and IT represent hydrostatic and colloid oncotic pressures, respectively, Kf is the pulmonary microvascular permeability coefficient, a-is the reflection coefficient ofthe capillary membrane, and Q lymph represents pulmonary lymphatic flow and any other factors removing liquid from the lung interstitium (14) . Because OA did not raise Pmv as deduced from the pulmonary vascular pressures (Table I) or lower 7rmv as deduced from protein concentrations (Table II) , the pulmonary edema is likely a result of a substantial increase in Kf, to a lesser extent to reduced 0a, and remotely to altered Pis, vris, or Q lymph. Once Kf is increased and a is reduced, the amount of edema flow is very sensitive to altered PIm1v and (quite insensitive to altered 7rmv (15) .
After receiving furosemide, dogs in group OA + F tended to inerease their mean Ppa (16.7-19.2 mmitHg) and to decrease their Ppwx (Table I) . During the same time, group OA dogs had a larger and statistically significant reduction in Ppw and tended to decrease Ppa (16.3-14.5 mmHg) . To the extent that the ratio of vascular resistance upstream and downstream from the site of major leak is not substantially altered by furosemide, these hemodynamic measurements indicate that Pmv increased in group OA + F compared with group OA during the 2 h after furosemide (16 (17, 18) , but the available evidence suggests that lymph flow changes in accord with factors governing QE, as if furosemide were having no direct effect on lymphatic mobility (19, 20) . One explanation of reduced shunt, reduced edema, and increased Ppa after furosemide is enhanced pulmonarv vasoconstriction in edemiatous lung regions. Such an effect of furosemide would reduce the fraction of total pulmonary blood flow going to nonventilated lung units. To the extent that such vasoconstriction was upstream from the major site of liquid leak, hydrostatic pressure there (Pmv) would tend to decrease after furosemide (21) . In turn, QE might decrease considerably for a small reduction in Pmv because Kf is high (15) . In our study, Ppa tended to increase after furosemide, and PVR, calculated as (Ppa -Ppw)/ Q(t, increased considerably. These hemodynamic measurements were made at end-expiration when alveolar pressure (Palv) was 0, so Ppw exceeded Palv in all lung regions in groups OA and OA + F. Accordingly, this calculation of PVR indicates narrowing of pulmonary vessels in group OA + F compared with group OA, and underestimates the narrowing to the extent Furosenl ide itn Lotw-Pre.s.sure Pulmotnary Edenma that increased Ppa in group OA + F recruits and distends pulmonary vascular bed (22) . Although reduced Qt is associated with increased PVR, Qt decreased by a similar amount in groups OA and OA + F between 2 and 4 h. Furthermore, iffurosemide is reducing edema, it seems likely that pulmonary vascular compression by edema is decreasing in group OA + F compared with group OA. These considerations suggest that PVR increased after furosemide in part as a result of pulmonary vasoconstriction. This vasoconstriction could reduce edema formation and shunt if it occurred predominantly upstream from the major site of leak in edematous lung regions.
We are unaware of conclusive studies of the effects of furosemide on pulmonary vascular tone in vivo. Furosemide blocks adrenergic constriction of mesenteric vessels (23) , and a brief communication suggests a similar action on intralobar pulmonary veins (24 Comparison of furosemide effects in high-vs. lowpressure pulmonary edema. Pulmonary edema secondary to left ventricular failure is quite responsive to furosemide. The reductions in symptoms, intrapulmonary shunt, and radiologic edema have been attributed to diuresis and the diuretic enhanced capacitance of the systemic veins. Both mechanisms reduce CBV, which in turn reduces Pmv in inverse proportion to the compliance ofthe pulmonary circulation. Consideration of our data in low-pressure edema focused our attention on the left ventricular diastolic compliance as the major determinant of APmv. Because the left ventricular diastolic volume-pressure characteristics are nonlinear (Fig. 4) (6) . In contrast, seven patients with normal central hemodynamics during the convalescent period of high altitude pulmonary edema had a small and insignificant reduction in mean atrial pressure from 5.0 to 3.5 mmHg when furosemide caused a much larger reduction in mean pulmonary blood volume from 327 to 252 ml (3). In normal adult sheep, 80 mg of furosemide caused mean PL, to decrease from 2.5 to 1.2 mmHg (20) . This small reduction in hydrostatic pressure was statistically significant and was associated with a 30% reduction in pulmonary lymph flow, which the investigators attributed to reduced steady-state edema formation. Similarly, Bland et al. (19) observed in eight normal lambs that PLa decreased from 2 to 1 mmHg (P < 0.05) associated with a 27% reduction in lymph flow. In five lambs given large saline loads in the same study, PLa increased to 9 mmHg. After furosemide, PLa decreased from 9 to 1 mmHg, and lymph flow was reduced to one-half of the control value. These data support the concept that furosemide has a much greater effect on Pmv in cardiogenic or high-pressure pulmonary edema than in pulmonary edema associated with low or normal vascular pressures, presumably because the left ventricular diastolic volume-pressure relationship is quite curvilinear.
Although the reduction in left ventricular diastolic pressure is much less in low-pressure edema, such small reductions may effectively reduce the edema formation rate because Kf is so high. In this setting, Pmv and its effects on edema may be affected as much by small changes in pulmonary vascular muscle tone as by altered ventricular diastolic volume. Pulmonary venous dilatation or pulmonary arteriolar constriction by furosemide could lower the hydrostatic pressure at the leak site by several millimeters of Mercury without detectable changes in Ppa or Ppw (16) . Similarly, pulmonary venous constriction or arteriolar dilation would increase Pmv and edema. These considerations suggest that even limited vasoactive effects of furosemide easily overlooked in cardiogenic edema might significantly alter low-pressure edema formation rate. This rationale applies to other pulmonary vasoactive drugs commonly used in acutely ill patients for other reasons; viz., nitroprusside, isoproterenol, and dopamine. Finally, the effects of these drugs on ventricular function and diastolic volume-pressure curves may significantly alter Pmv and edema. Apparently, furosemide has no such effects on canine left ventricular function (25) .
In summary, out attempt to determine the mechanism of action of furosemide in a canine model of low-pressure pulmonary edema revealed several surprising differences from cardiogenic edema. First, pulmonary oxygen exchange was considerably improved 2 h after furosemide with only equivocal reductions in the amount of edema. Second, if the edema were reduced by furosemide, this effect could not be attributed to measured reductions in Ppw or Ppa. Accordingly, both the improved gas exchange and the reduced edema are as likely a result of the pulmonary vasoactive effects of furosemide redistributing pulmonary blood flow away from edematous areas and the lowering the hydrostatic pressure in pulmonary microvessels. Such effects are less important and unreported in cardiogenic edema, where furosemide-induced reduction in CBV causes a large reduction in Pmv, edema, and shunt because of the low diastolic compliance of the distended ischemic left ventricle.
Although furosemide produces smaller reductions in Pmv in low-pressure edema, it seems reasonable to employ this therapy because even minor reductions in Pmv markedly reduce the rate of edema formation when pulmonary capillary permeability is increased. Such an approach requires careful monitoring of some estimate of Pmv and the awareness that altered pulmonary vascular tone might confound estimates based on measured Ppa and Ppw. One approach is to use diuretics and fluid restriction to seek the lowest Ppw consistent with adequate cardiac output. An acknowledged pulmonary risk of induced circulatory hypovolemia is that it may increase the permeability per se (26) . Another potential problem is that potent loop diuretics obscure the early detection of renal hypoperfusion by prerenal oliguria. Conceivably, reduced Qt and renal blood flow during circulatory hypovolemia can be prevented by vasoactive agents such as dopamine used in the dopaminergic range (3-5 ug/kg per min). Finally, when further reduction in Pmv and edema is sought after circulating blood volume and Qt are reduced to acceptable limits, agents which alter left ventricular diastolic compliance or systolic pumping function may be effective. Because each vasoactive agent employed may have significant and independent effects on pulmonary shunt and pulmonary edema formation, measured changes in Qs/Qt are only loose and indirect indicators of edema rate in pulmonary capillary leak. Further attempts to test these complicated therapeutic considerations seem warranted because current therapy of pulmonary capillary leak is associated with high mortality (27) .
